VanEck Associates’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $403K | Buy |
|
|||||
|
2025
Q1 | $399K | Buy |
|
|||||
|
2024
Q4 | $628K | Sell |
|
|||||
|
2024
Q3 | $392K | Buy |
|
|||||
|
2024
Q2 | $409K | Buy |
|
|||||
|
2024
Q1 | $247K | Buy |
|
|||||
|
2023
Q4 | $225K | Sell |
|
|||||
|
2023
Q3 | $243K | Buy |
|
|||||
|
2023
Q2 | $586K | Sell |
|
|||||
|
2023
Q1 | $971K | Sell |
|
|||||
|
2022
Q4 | $1.2M | Buy |
|
|||||
|
2022
Q3 | $1.03M | Buy |
|
|||||
|
2022
Q2 | $937K | Sell |
|
|||||
|
2022
Q1 | $1.5M | Buy |
|
|||||
|
2021
Q4 | $1.35M | Sell |
|
|||||
|
2021
Q3 | $2.22M | Sell |
|
|||||
|
2021
Q2 | $4.58M | Buy |
|
|||||
|
2021
Q1 | $2.52M | Buy |
|
|||||
|
2020
Q4 | $3.25M | Sell |
|
|||||
|
2020
Q3 | $3.2M | Buy |
|
|||||
|
2020
Q2 | $1.67M | Buy |
|
|||||
|
2020
Q1 | $1.88M | Buy |
|
|||||
|
2019
Q4 | $2.27M | Buy |
|
|||||
|
2019
Q3 | $1.95M | Buy |
|
|||||
|
2019
Q2 | $1.64M | Buy |
|
|||||
|
2019
Q1 | $1.1M | Buy |
|
|||||
|
2018
Q4 | $749K | Buy |
|
|||||
|
2018
Q3 | $996K | Buy |
|
|||||
|
2018
Q2 | $561K | Sell |
|
|||||
|
2018
Q1 | $418K | Buy |
|
|||||
|
2017
Q4 | $361K | Sell |
|
|||||
|
2017
Q3 | $382K | Buy |
|
|||||
|
2017
Q2 | $318K | Buy |
|